Status
Conditions
Treatments
About
This is observational study to assess the prognosis of patients hospitalized with COVID-19 confirmed by RT-PCR and exposed to trimethylxanthine (TMX).
Trimethylxanthine is the active molecule present in coffee. Due to the lack of etiologic treatments and considering interest about old treatments as an avenue for research, we conducted a comparative study aiming to evaluate the effect of 1,3,7-trimethylxanthine on COVID-19 infected patients. This is actually a study about methodology.
The objective of this study is therefore not to demonstrate the effect of the substance on the disease but the importance of a rigorous methodology in scientific research. This project is called "Method and Teaching of Scientific Studies".
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
93 participants in 2 patient groups
Loading...
Central trial contact
Alexandre BLEIBTREU; Paul ROBLOT
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal